NEW YORK (GenomeWeb News) – OriGene Technologies today announced the completion of its $21.3 million Series C financing round.

Qiming Venture Partners and Kleiner Perkins Caufield Byers China led the round, while existing investor IDG-Accel also participated, OriGene said.

The company intends to use the financing to "advance our growth strategy and operations," Wei-Wu He, OriGene's chairman and CEO, said in a statement, without elaborating.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers examine the gap in funding between researchers and research institutions, ScienceInsider reports

By sequencing two ancient dog genomes, researchers from the US and Germany suggest that dogs were domesticated in a single event, the Washington Post reports.

In Genome Research this week: population dynamics of E. coli infection, lncRNA expression changes in macaque aging, and more.

Noninvasive prenatal testing can uncover pregnancies at risk of miscarriage, New Scientist reports.